carbachol has been researched along with Sclerosis, Systemic in 3 studies
Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dysphagia was present only in 11 patients (44%)." | 2.64 | Esophageal dysfunction and its pathogenesis in progressive systemic sclerosis. ( Ewe, K; Korting, GW; Vogt, G; Weihrauch, TR, 1978) |
| "Fibrosis was quantified using the NIS Elements BR 2." | 1.38 | Gut fibrosis with altered colonic contractility in a mouse model of scleroderma. ( Denton, CP; Derrett-Smith, EC; Dooley, A; Khan, K; Shi-Wen, X; Thoua, NM, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thoua, NM | 1 |
| Derrett-Smith, EC | 1 |
| Khan, K | 1 |
| Dooley, A | 1 |
| Shi-Wen, X | 1 |
| Denton, CP | 1 |
| Goldblatt, F | 1 |
| Gordon, TP | 1 |
| Waterman, SA | 1 |
| Weihrauch, TR | 1 |
| Korting, GW | 1 |
| Ewe, K | 1 |
| Vogt, G | 1 |
1 trial available for carbachol and Sclerosis, Systemic
| Article | Year |
|---|---|
Esophageal dysfunction and its pathogenesis in progressive systemic sclerosis.
Topics: Adult; Aged; Carbachol; Deglutition Disorders; Esophagus; Female; Humans; Male; Manometry; Middle Ag | 1978 |
2 other studies available for carbachol and Sclerosis, Systemic
| Article | Year |
|---|---|
Gut fibrosis with altered colonic contractility in a mouse model of scleroderma.
Topics: Animals; Carbachol; Cholinergic Agonists; Colon; Colonic Diseases; Female; Fibroblasts; Fibrosis; Ga | 2012 |
Antibody-mediated gastrointestinal dysmotility in scleroderma.
Topics: Aged; Animals; Autoantibodies; Calcium Channels, L-Type; Carbachol; Cholinergic Agonists; Colon; Fem | 2002 |